Literature DB >> 33500482

Assessing the functional impact of PfRh5 genetic diversity on ex vivo erythrocyte invasion inhibition.

Alassane Mbengue1,2, Amy K Bei3,4, Adam J Moore5, Khadidiatou Mangou1, Fatoumata Diallo1, Seynabou D Sene1, Mariama N Pouye1, Bacary D Sadio6, Ousmane Faye6.   

Abstract

The PfRh5-Basigin ligand-receptor interaction is an essential step in the merozoite invasion process and represents an attractive vaccine target. To reveal genotype-phenotype associations between naturally occurring allelic variants of PfRh5 and invasion inhibition, we performed ex vivo invasion inhibition assays with monoclonal antibodies targeting basigin coupled with PfRh5 next-generation amplicon sequencing. We found dose-dependent inhibition of invasion across all isolates tested, and no statistically significant difference in invasion inhibition for any single nucleotide polymorphisms. This study demonstrates that PfRh5 remains highly conserved and functionally essential, even in a highly endemic setting, supporting continued development as a strain-transcendent malaria vaccine target.

Entities:  

Year:  2021        PMID: 33500482      PMCID: PMC7838290          DOI: 10.1038/s41598-021-81711-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  18 in total

1.  Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans.

Authors:  Saurabh D Patel; Ambroise D Ahouidi; Amy K Bei; Tandakha N Dieye; Souleymane Mboup; Stephen C Harrison; Manoj T Duraisingh
Journal:  J Infect Dis       Date:  2013-07-31       Impact factor: 5.226

2.  Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion.

Authors:  Karen Hayton; Deepak Gaur; Anna Liu; Jonathan Takahashi; Bruce Henschen; Subhash Singh; Lynn Lambert; Tetsuya Furuya; Rachel Bouttenot; Michelle Doll; Fatima Nawaz; Jianbing Mu; Lubin Jiang; Louis H Miller; Thomas E Wellems
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

3.  Measuring precision in bioassays: Rethinking assay validation.

Authors:  Michael P Fay; Michael C Sachs; Kazutoyo Miura
Journal:  Stat Med       Date:  2017-10-19       Impact factor: 2.373

4.  Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.

Authors:  Olusola Ajibaye; Akinniyi A Osuntoki; Emmanuel O Balogun; Yetunde A Olukosi; Bamidele A Iwalokun; Kolapo M Oyebola; Kenji Hikosaka; Yoh-Ichi Watanabe; Godwin U Ebiloma; Kiyoshi Kita; Alfred Amambua-Ngwa
Journal:  Malar J       Date:  2020-01-06       Impact factor: 2.979

5.  Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.

Authors:  Ruth O Payne; Sarah E Silk; Sean C Elias; Kazutoyo Miura; Ababacar Diouf; Francis Galaway; Hans de Graaf; Nathan J Brendish; Ian D Poulton; Oliver J Griffiths; Nick J Edwards; Jing Jin; Geneviève M Labbé; Daniel Gw Alanine; Loredana Siani; Stefania Di Marco; Rachel Roberts; Nicky Green; Eleanor Berrie; Andrew S Ishizuka; Carolyn M Nielsen; Martino Bardelli; Frederica D Partey; Michael F Ofori; Lea Barfod; Juliana Wambua; Linda M Murungi; Faith H Osier; Sumi Biswas; James S McCarthy; Angela M Minassian; Rebecca Ashfield; Nicola K Viebig; Fay L Nugent; Alexander D Douglas; Johan Vekemans; Gavin J Wright; Saul N Faust; Adrian Vs Hill; Carole A Long; Alison M Lawrie; Simon J Draper
Journal:  JCI Insight       Date:  2017-11-02

6.  Basigin is a druggable target for host-oriented antimalarial interventions.

Authors:  Zenon A Zenonos; Sara K Dummler; Nicole Müller-Sienerth; Jianzhu Chen; Peter R Preiser; Julian C Rayner; Gavin J Wright
Journal:  J Exp Med       Date:  2015-07-20       Impact factor: 14.307

7.  Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies.

Authors:  Katherine E Wright; Kathryn A Hjerrild; Jonathan Bartlett; Alexander D Douglas; Jing Jin; Rebecca E Brown; Joseph J Illingworth; Rebecca Ashfield; Stine B Clemmensen; Willem A de Jongh; Simon J Draper; Matthew K Higgins
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

8.  P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5.

Authors:  Francis Galaway; Laura G Drought; Maria Fala; Nadia Cross; Alison C Kemp; Julian C Rayner; Gavin J Wright
Journal:  Nat Commun       Date:  2017-02-10       Impact factor: 14.919

9.  A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates.

Authors:  Alexander D Douglas; G Christian Baldeviano; Jing Jin; Kazutoyo Miura; Ababacar Diouf; Zenon A Zenonos; Julio A Ventocilla; Sarah E Silk; Jennifer M Marshall; Daniel G W Alanine; Chuan Wang; Nick J Edwards; Karina P Leiva; Luis A Gomez-Puerta; Carmen M Lucas; Gavin J Wright; Carole A Long; Joseph M Royal; Simon J Draper
Journal:  Nat Commun       Date:  2019-04-26       Impact factor: 14.919

10.  Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.

Authors:  Alexander D Douglas; Andrew R Williams; Ellen Knuepfer; Joseph J Illingworth; Julie M Furze; Cécile Crosnier; Prateek Choudhary; Leyla Y Bustamante; Sara E Zakutansky; Dennis K Awuah; Daniel G W Alanine; Michel Theron; Andrew Worth; Richard Shimkets; Julian C Rayner; Anthony A Holder; Gavin J Wright; Simon J Draper
Journal:  J Immunol       Date:  2013-11-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.